Publication | Closed Access

Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography–ultraviolet detection and liquid chromatography–tandem mass spectrometry: Methods’ comparison

Hematological MalignancyBioanalysisHematologyMass SpectrometryPathologyMyeloid NeoplasiaAnalytical ChemistryImatinib Plasma LevelsChronic MyeloidClinical ChemistryMedicineRadiation OncologyChromatographyHealth Sciences